Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Alpha Metallurgical Resources, Inc.Alpha Metallurgical Resources Reports $2.96 Billion Revenue for 2024, 14.8% Decrease
Praxis Precision Medicines, Inc.Praxis Precision Medicines Reports $182.8 Million Net Loss for 2024, Highlights Funding and Clinical Developments
Bit Digital, IncBit Digital Reports $28.3 Million Net Income for Fiscal Year 2024, Driven by Revenue Growth
Akero Therapeutics, Inc.Akero Therapeutics Reports $252M Net Loss for 2024, Increases R&D Spending
RECURSION PHARMACEUTICALS, INC.Recursion Pharmaceuticals Reports $463.6M Net Loss and $58.8M Revenue in 2024
ANI PHARMACEUTICALS INCANI Pharmaceuticals Reports $18.5 Million Net Loss Despite 26.2% Revenue Growth in 2024
Apellis Pharmaceuticals, Inc.Apellis Pharmaceuticals Reports $197.8 Million Net Loss for 2024, Significant Revenue Growth Driven by SYFOVRE
Tonix Pharmaceuticals Holding Corp.Tonix Pharmaceuticals Reports $130M Net Loss and $10.1M Revenue for Fiscal Year 2024
Esperion Therapeutics, Inc.Esperion Therapeutics Reports $51.7 Million Net Loss for 2024, Improved from $209.2 Million in 2023
scPharmaceuticals Inc.ScPharmaceuticals Reports $85.1 Million Net Loss for 2024, Despite Revenue Growth from FUROSCIX
ProShares Trust IIProShares Trust II Reports Financial Performance for Year Ended December 31, 2024
Veradigm Inc.Veradigm Inc. Reports $86.4 Million Net Loss and $588 Million Revenue for 2022
Silexion Therapeutics CorpSilexion Therapeutics Reports $16.5 Million Net Loss for 2024, Plans Phase 2/3 Trial for SIL204
Infinera CorpInfinera Reports 12% Revenue Decline in Fiscal Year 2024, Anticipates Merger with Nokia
HOOKIPA Pharma Inc.HOOKIPA Pharma Reports $43.5M Net Loss for 2024, Improved Revenue and Restructuring Plan
Absci CorpAbsci Corp. Reports $4.5 Million Revenue Decline and $103.1 Million Net Loss for Fiscal Year 2024
Grayscale Ethereum Staking ETFGrayscale Ethereum Trust Reports $2.77B Gain in Ether Investments for 2024
Grayscale Ethereum Staking Mini ETFGrayscale Ethereum Mini Trust ETF Reports $32.8 Million Loss on Ether Investments
Grayscale Bitcoin Mini Trust ETFGrayscale Bitcoin Mini Trust ETF Reports $980M Gain and Operational Changes for 2024
Olema Pharmaceuticals, Inc.Olema Pharmaceuticals Reports $129.4 Million Net Loss for 2024, Increased R&D Expenses
Natera, Inc.Natera Reports 56.7% Revenue Growth to $1.7 Billion in 2024
MARAVAI LIFESCIENCES HOLDINGS, INC.Maravai LifeSciences Reports $259.6M Net Loss and 10.3% Revenue Decline for 2024
MASTEC INCMasTec Inc. Reports $199.4 Million Net Income and $12.3 Billion Revenue for Fiscal Year 2024
Grayscale Bitcoin Trust ETFGrayscale Bitcoin Trust ETF Reports $16.38 Million Gain for 2024, Sees 27% Decrease in Net Assets
VERACYTE, INC.Veracyte Reports $24.1 Million Net Income and 23% Revenue Growth for Fiscal Year 2024